Breaking News

Copley Scientific Launches Breath Actuation Controller

The new BACTM 2100 includes more features than ever before

Copley Scientific has launched the BACTM 2100, an advanced Breath Actuation Controller to help automate flow control when testing metered- dose inhalers (MDIs) for delivered dose uniformity and aerodynamic particle size distribution.    The new BACTM 2100, which replaces its predecessor, the BACTM 2000, provides flow control for a range of MDI applications, including a time delay feature for the actuation of MDIs when used with spacers and valved holding chambers. It can also be used for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters